Position in UTHR
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$506,404
+$16,718 QoQ
Shares Held
854
-15.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PINNACLE ASSOCIATES LTD holds $9,412,989 across 7 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EOLS |
Evolus, Inc.
|
1,158,895 | $4,763,058 | |
| 2 | ZTS |
Zoetis Inc.
|
18,117 | $2,141,610 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
22,707 | $1,345,843 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
854 | $506,404 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
5,484 | $303,320 | |
| 6 | VTRS |
Viatris Inc
|
13,981 | $188,883 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
59,807 | $163,871 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $506,404 | 854 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $489,686 | 1,005 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $339,560 | 810 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $247,121 | 860 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $249,698 | 810 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $285,800 | 810 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $289,880 | 910 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $220,531 | 960 | Shares | Sole | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||